Approval Year
Substance Class |
Structurally Diverse
Created
by
admin
on
Edited
Sat Dec 16 12:20:19 GMT 2023
by
admin
on
Sat Dec 16 12:20:19 GMT 2023
|
Source Materials Class | ORGANISM |
Source Materials Type | VIRUS |
Source Materials State | INACTIVATED |
Source Materials Parent | |
Author | NONE |
Infraspecific Type | STRAIN |
Infraspecific Name | HM175 |
Part | WHOLE |
Record UNII |
5BFC8LZ6LQ
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NDF-RT |
N0000183889
Created by
admin on Sat Dec 16 12:20:19 GMT 2023 , Edited by admin on Sat Dec 16 12:20:19 GMT 2023
|
||
|
NCI_THESAURUS |
C75673
Created by
admin on Sat Dec 16 12:20:19 GMT 2023 , Edited by admin on Sat Dec 16 12:20:19 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
N0000183364
Created by
admin on Sat Dec 16 12:20:19 GMT 2023 , Edited by admin on Sat Dec 16 12:20:19 GMT 2023
|
PRIMARY | Actively Acquired Immunity [PE] | ||
|
C75674
Created by
admin on Sat Dec 16 12:20:19 GMT 2023 , Edited by admin on Sat Dec 16 12:20:19 GMT 2023
|
PRIMARY | |||
|
N0000170916
Created by
admin on Sat Dec 16 12:20:19 GMT 2023 , Edited by admin on Sat Dec 16 12:20:19 GMT 2023
|
PRIMARY | Vaccines, Inactivated [Chemical/Ingredient] | ||
|
DBSALT001980
Created by
admin on Sat Dec 16 12:20:19 GMT 2023 , Edited by admin on Sat Dec 16 12:20:19 GMT 2023
|
PRIMARY | |||
|
5BFC8LZ6LQ
Created by
admin on Sat Dec 16 12:20:19 GMT 2023 , Edited by admin on Sat Dec 16 12:20:19 GMT 2023
|
PRIMARY | |||
|
467420-42-4
Created by
admin on Sat Dec 16 12:20:19 GMT 2023 , Edited by admin on Sat Dec 16 12:20:19 GMT 2023
|
PRIMARY | SCIFINDER | ||
|
NCT00875485
Created by
admin on Sat Dec 16 12:20:19 GMT 2023 , Edited by admin on Sat Dec 16 12:20:19 GMT 2023
|
PRIMARY | EVALUATION OF ANTIBODY PERSISTENCE & IMMUNE MEMORY IN SUBJECTS VACCINATED DURING ADOLESCENCE WITH TWINRIX | ||
|
Hepatitis A and B vaccine
Created by
admin on Sat Dec 16 12:20:19 GMT 2023 , Edited by admin on Sat Dec 16 12:20:19 GMT 2023
|
PRIMARY | |||
|
5BFC8LZ6LQ
Created by
admin on Sat Dec 16 12:20:19 GMT 2023 , Edited by admin on Sat Dec 16 12:20:19 GMT 2023
|
PRIMARY | |||
|
798361
Created by
admin on Sat Dec 16 12:20:19 GMT 2023 , Edited by admin on Sat Dec 16 12:20:19 GMT 2023
|
PRIMARY | RxNorm | ||
|
N0000170896
Created by
admin on Sat Dec 16 12:20:19 GMT 2023 , Edited by admin on Sat Dec 16 12:20:19 GMT 2023
|
PRIMARY | Hepatitis A Vaccines [Chemical/Ingredient] |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET ORGANISM->VACCINE ANTIGEN |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
Agent Modifications
Modification Process | Modification Role | Modification Type | Amount | Fragment Name | Fragment ID |
---|---|---|---|---|---|
INACTIVATION | CHEMICAL |
|
Formaldehyde | 1HG84L3525 |